Crop Logic enters into CBD joint venture
Published 26-JUL-2019 11:24 A.M.
|
3 minute read
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
CropLogic Limited (ASX:CLI) has entered into a joint venture (JV) with experienced Oregonian agriculturalists, the Shephard Brothers.
The JV will see the companies work together to grow premium CBD hemp trimmed flower, with CropLogic implementing its agricultural skillset and agtech over an additional 16.6 acres of premium hemp, cultivated specifically to produce trimmed CBD flower (as opposed to bio-mass).
Trimmed flower is modelled to have a significantly higher return on investment than hemp biomass. It is a premium CBD hemp product that attracts a high sale price.
Prices of US$450/lb have been commonly observed by CropLogic and price ranges of between US$300 to US$600/lb being common (price variance largely due to grade, marketing and quantity).
The Shephard Brothers are famous in Oregon. Their nursery supplies much of the blooming stock (flowers and vegetables) to much of the west coast including some of the largest chain stores in the USA.
The brothers are experienced agriculturalists. They will demonstrate CropLogic’s digital applications, including CropLogic realTime1 over CBD hemp trimmed flower production. Their contribution to the JV will include providing acreage, shedding and storage and also labour and machining during the trimming process.
CropLogic will provide hemp plant management expertise as well farm management, agronomy and agtech expertise.
Proceeds from the joint venture will split equally. It is expected this venture will produce between 8,000 and 10,500 lbs of trimmed flower.
“Local interest in CropLogic’s Hemp Trial Farm has drawn much local attention to CropLogic and in particular our agronomy, farm management and agtech expertise,” said CropLogic CEO James Cooper-Jones.
“We have drawn on this interest and joined with the Shephard Brothers to develop a premium CBD hemp trimmed flower product to demonstrate CropLogic’s farm management, agronomy and agtech expertise.
CropLogic realTime monitors and tracks key crop metrics, such as soil moisture and irrigation, and converts observations into data 24/7. This information is then collated in a concise and accurate format, providing actionable insights for users to make cost-saving decisions. Users can view this data in a user-friendly application called CropLogic GrowerView, which can be accessed via desktop, as well as on both Android and Apple iOS. CropLogic has developed this tool with the expertise of leading agronomists, leveraging over 30 years of research.
“We are pleased to partner with agriculturalists of the calibre of the Shephard Brothers and are keen in expanding CropLogic’s proprietary knowledge of not only hemp, an exciting and emerging crop, but also expand our knowledge of cropping generally.
“The Shephard Brothers’ understanding of plant development including flowering will be of great benefit to CropLogic, as will their experience in marketing and product positioning.”
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
